[Special Stock] Pharmicell's Stock Soars Following US Monkeypox Emergency Declaration
![[Special Stock] Pharmicell's Stock Soars Following US Monkeypox Emergency Declaration](http://www.asiae.co.kr/news/img_view.htm?img=2016012914025477581_1.jpg)
[Asia Economy Reporter Minji Lee] Pamicell, a stock related to monkeypox, is showing a sharp rise during trading hours.
At 10:54 AM on the 5th, Pamicell was trading at 13,900 KRW, up 10.32% compared to the previous trading day.
The U.S. government's declaration of a public health emergency related to monkeypox is analyzed to have influenced the stock price. This measure aims to strengthen the federal government's response to monkeypox, which continues to see increasing infections worldwide. Currently, the number of monkeypox cases in the U.S. has surpassed 6,600 since the first case was reported in mid-May, indicating a spreading trend.
The World Health Organization (WHO) had already declared monkeypox an international public health emergency on the 23rd of last month.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Since 2007, Pamicell has been the exclusive supplier of HDP-Tosylate, a key intermediate used in the smallpox treatment drug 'Brincidofovir' being developed by the U.S. biotech company Chimerix.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
